Works by Ip, Michael

Results: 53

Visit Adherence and Visual Acuity in Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2).

Published in:

Ophthalmic Epidemiology, 2024, v. 31, n. 1, p. 78, doi. 10.1080/09286586.2023.2187070

By:

VanderBeek, Brian L.;
Yu, Yinxi;
Oden, Neal;
VanVeldhuisen, Paul;
Blodi, Barbara;
Ip, Michael;
Scott, Ingrid U.

Publication type:

Article

Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial.

Published in:

JAMA Ophthalmology, 2023, v. 141, n. 12, p. 1152, doi. 10.1001/jamaophthalmol.2023.5248

By:

Singh, Rishi P.;
Barakat, Mark R.;
Ip, Michael S.;
Wykoff, Charles C.;
Eichenbaum, David A.;
Joshi, Sunir;
Warrow, David;
Sheth, Veeral S.;
Stefanickova, Jana;
Kim, Yong Soo;
He, Fanyin;
Cho, Ga Eun;
Wang, Yuhua;
Emanuelli, Andrés

Publication type:

Article

Intraocular Pressure in Eyes With Retinal Vein Occlusion Compared With Fellow Eyes: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 27.

Published in:

JAMA Ophthalmology, 2023, v. 141, n. 12, p. 1172, doi. 10.1001/jamaophthalmol.2023.5159

By:

Aref, Ahmad A.;
Scott, Ingrid U.;
Oden, Neal L.;
Ip, Michael S.;
VanVeldhuisen, Paul C.;
Blodi, Barbara A.

Publication type:

Article

Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial.

Published in:

JAMA Ophthalmology, 2023, v. 141, n. 6, p. 554, doi. 10.1001/jamaophthalmol.2023.1463

By:

Kymes, Steven M.;
Oden, Neal L.;
VanVeldhuisen, Paul C.;
Scott, Ingrid U.;
Ip, Michael S.;
Blodi, Barbara A.;
King, Jacquie

Publication type:

Article

Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.

Published in:

2022

By:

Scott, Ingrid U.;
Oden, Neal L.;
VanVeldhuisen, Paul C.;
Ip, Michael S.;
Blodi, Barbara A.;
SCORE2 Study Investigator Group

Publication type:

journal article

Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration: A Post Hoc Analysis of the FILLY Randomized Clinical Trial.

Published in:

2022

By:

Nittala, Muneeswar Gupta;
Metlapally, Ravi;
Ip, Michael;
Chakravarthy, Usha;
Holz, Frank G.;
Staurenghi, Giovanni;
Waheed, Nadia;
Velaga, Swetha Bindu;
Lindenberg, Sophiana;
Karamat, Ayesha;
Koester, John;
Ribeiro, Ramiro;
Sadda, SriniVas

Publication type:

journal article

Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial

Published in:

2021

By:

Aref, Ahmad A.;
Scott, Ingrid U.;
VanVeldhuisen, Paul C.;
King, Jacquie;
Ip, Michael S.;
Blodi, Barbara A.;
Oden, Neal L.;
Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group

Publication type:

journal article

Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months: ProgStar Report No. 13.

Published in:

2020

By:

Schönbach, Etienne M.;
Strauss, Rupert W.;
Muñoz, Beatriz;
Wolfson, Yulia;
Ibrahim, Mohamed A.;
Birch, David G.;
Zrenner, Eberhart;
Sunness, Janet S.;
Ip, Michael S.;
Sadda, SriniVas R.;
West, Sheila K.;
Scholl, Hendrik P. N.;
ProgStar Study Group

Publication type:

journal article

Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial.

Published in:

2019

By:

Scott, Ingrid U.;
Oden, Neal L.;
VanVeldhuisen, Paul C.;
Ip, Michael S.;
Blodi, Barbara A.;
Chan, Clement K.;
SCORE2 Investigator Group

Publication type:

journal article

Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11.

Published in:

JAMA Ophthalmology, 2019, v. 137, n. 10, p. 1134, doi. 10.1001/jamaophthalmol.2019.2885

By:

Strauss, Rupert W.;
Kong, Xiangrong;
Ho, Alexander;
Jha, Anamika;
West, Sheila;
Ip, Michael;
Bernstein, Paul S.;
Birch, David G.;
Cideciyan, Artur V.;
Michaelides, Michel;
Sahel, José-Alain;
Sunness, Janet S.;
Traboulsi, Elias I.;
Zrenner, Eberhart;
Pitetta, Sean;
Jenkins, Dennis;
Hariri, Amir Hossein;
Sadda, SriniVas;
Scholl, Hendrik P. N.

Publication type:

Article

Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11.

Published in:

2019

By:

Strauss, Rupert W;
Kong, Xiangrong;
Ho, Alexander;
Jha, Anamika;
West, Sheila;
Ip, Michael;
Bernstein, Paul S;
Birch, David G;
Cideciyan, Artur V;
Michaelides, Michel;
Sahel, José-Alain;
Sunness, Janet S;
Traboulsi, Elias I;
Zrenner, Eberhart;
Pitetta, Sean;
Jenkins, Dennis;
Hariri, Amir Hossein;
Sadda, SriniVas;
Scholl, Hendrik P N;
ProgStar Study Group

Publication type:

journal article

Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial.

Published in:

2019

By:

Scott, Ingrid U.;
VanVeldhuisen, Paul C.;
Barton, Franca;
Oden, Neal L.;
Ip, Michael S.;
Blodi, Barbara A.;
Worrall, Martin;
Fish, Gary E.;
Study of Comparative Treatments for Retinal Vein Occlusion 2 Investigator Group

Publication type:

journal article

Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study.

Published in:

2019

By:

Ip, Michael S.;
Oden, Neal L.;
Scott, Ingrid U.;
VanVeldhuisen, Paul C.;
Blodi, Barbara A.;
Ghuman, Thomas;
Baker, Carl W.;
SCORE2 Investigator Group

Publication type:

journal article

Treatment of Central Retinal Vein Occlusion-A New Look at a Blast From the Past.

Published in:

2018

By:

Ip, Michael S.

Publication type:

journal article

Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial.

Published in:

2018

By:

Scott, Ingrid U.;
VanVeldhuisen, Paul C.;
Ip, Michael S.;
Blodi, Barbara A.;
Oden, Neal L.;
Altaweel, Michael;
Berinstein, Daniel M.;
SCORE2 Investigator Group

Publication type:

journal article

Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.

Published in:

2017

By:

Scott, Ingrid U.;
VanVeldhuisen, Paul C.;
Ip, Michael S.;
Blodi, Barbara A.;
Oden, Neal L.;
King, Jacqueline;
Antoszyk, Andrew N.;
Peters, Mark A.;
Tolentino, Michael;
SCORE2 Investigator Group

Publication type:

journal article

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.

Published in:

2015

By:

Aref, Ahmad A;
Scott, Ingrid U;
Oden, Neal L;
Ip, Michael S;
Blodi, Barbara A;
VanVeldhuisen, Paul C;
SCORE Study Investigator Group

Publication type:

journal article

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion.

Published in:

JAMA Ophthalmology, 2015, v. 133, n. 9, p. 1022, doi. 10.1001/jamaophthalmol.2015.1823

By:

Aref, Ahmad A.;
Scott, Ingrid U.;
Oden, Neal L.;
Ip, Michael S.;
Blodi, Barbara A.;
VanVeldhuisen, Paul C.

Publication type:

Article

Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism.

Published in:

2013

By:

Lavine, Jeremy A;
Sang, Yanzhi;
Wang, Shoujian;
Ip, Michael S;
Sheibani, Nader

Publication type:

journal article

Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel.

Published in:

Clinical Ophthalmology, 2024, v. 18, p. 325, doi. 10.2147/OPTH.S445755

By:

Regillo, Carl D;
Nijm, Lisa M;
Shechtman, Diana L;
Kaiser, Peter K;
Karpecki, Paul M;
Ryan, Edwin H;
Ip, Michael S;
Yeu, Elizabeth;
Kim, Terry;
Rafieetary, Mohammad R;
Donnenfeld, Eric D

Publication type:

Article

A semi-automated machine-learning based workflow for ellipsoid zone analysis in eyes with macular edema: SCORE2 pilot study.

Published in:

PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0232494

By:

Etheridge, Tyler;
Dobson, Ellen T. A.;
Wiedenmann, Marcel;
Papudesu, Chandana;
Scott, Ingrid U.;
Ip, Michael S.;
Eliceiri, Kevin W.;
Blodi, Barbara A.;
Domalpally, Amitha

Publication type:

Article

Michaelis-Menten Analysis of Alkaline Phosphatase by Capillary Electrophoresis Using Plug-Plug Reaction.

Published in:

Journal of Liquid Chromatography & Related Technologies, 1998, v. 21, n. 18, p. 2781, doi. 10.1080/10826079808003442

By:

Xu, Yan;
Liu, Xuhui;
Ip, Michael P. C.

Publication type:

Article

Diabetic retinopathy debate resurfaces with new views.

Published in:

Ophthalmology Times Europe, 2016, v. 12, n. 6, p. 28

By:

Gebhart, Fred;
Ip, Michael S.;
Singh, Rishi P.

Publication type:

Article

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry.

Published in:

Ophthalmology & Therapy, 2024, v. 13, n. 5, p. 1357, doi. 10.1007/s40123-024-00920-3

By:

Zarbin, Marco A.;
MacCumber, Mathew W.;
Karcher, Helene;
Adiguzel, Eser;
Mayhook, Andrew;
LaPrise, Andrew;
Bilano, Ver L.;
Igwe, Franklin;
Ip, Michael S.;
Wykoff, Charles C.

Publication type:

Article

Alcohol Availability Across Neighborhoods in Ontario Following Alcohol Sales Deregulation, 2013–2017.

Published in:

American Journal of Public Health, 2019, v. 109, n. 6, p. 899, doi. 10.2105/AJPH.2019.305014

By:

Myran, Daniel T.;
Chen, Jarvis T.;
Bearnot, Benjamin;
Ip, Michael;
Giesbrecht, Norman;
Rees, Vaughan W.

Publication type:

Article

Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis.

Published in:

2010

By:

Nema, Nitin;
Ip, Michael S.

Publication type:

Case Study

POINT / COUNTER.

Published in:

Ocular Surgery News, 2009, v. 27, n. 9, p. 11

By:

Ip, Michael S.;
Cunha-Vaz, José G.

Publication type:

Article

Current treatment of exudative AMD.

Published in:

Ocular Surgery News, 2008, v. 26, p. 8

By:

Ip, Michael S.

Publication type:

Article

Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema.

Published in:

2004

By:

Ip, Michael S

Publication type:

journal article

Intravitreal Injections of Triamcinolone.

Published in:

Diabetes Care, 2004, v. 27, n. 7, p. 1794

By:

Ip, Michael S.

Publication type:

Article

The Effect of Elastase on Pulmonary Elastin and Collagen: Comparison of Intravenous and Intratracheal Exposure.

Published in:

Experimental Lung Research, 1980, v. 1, n. 3, p. 181, doi. 10.3109/01902148009065458

By:

Ip, Michael P. C.;
Kleinerman, Jerome;
Sorensen, Joan

Publication type:

Article

Month 60 Outcomes After Treatment Initiation With Anti--Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion.

Published in:

Transactions of the American Ophthalmological Society, 2022, v. 120, p. 330, doi. 10.1016/j.ajo.2022.04.001

By:

SCOTT, INGRID U.;
VANVELDHUISEN, PAUL C.;
ODEN, NEAL L.;
IP, MICHAEL S.;
BLODI, BARBARA A.

Publication type:

Article

Diabetic Macular Edema: Therapeutic Options.

Published in:

Diabetes Therapy, 2012, v. 3, n. 1, p. 1, doi. 10.1007/s13300-012-0002-y

By:

Kulkarni, Amol;
Ip, Michael

Publication type:

Article

Choriocapillaris flow impairment surrounding geographic atrophy correlates with disease progression.

Published in:

PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0212563

By:

Nassisi, Marco;
Baghdasaryan, Elmira;
Borrelli, Enrico;
Ip, Michael;
Sadda, Srinivas R.

Publication type:

Article

Intravitreal steroid versus macular laser for treatment of diabetic macular edema.

Published in:

Current Diabetes Reports, 2009, v. 9, n. 4, p. 272, doi. 10.1007/s11892-009-0042-5

By:

Gunther, Jonathan;
Ip, Michael

Publication type:

Article

Mechanisms of Epithelial-Mesenchymal Transition and Prevention of Dispase-Induced PVR by Delivery of an Antioxidant αB Crystallin Peptide †.

Published in:

Antioxidants, 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/antiox11102080

By:

Wada, Iori;
Sreekumar, Parameswaran G;
Spee, Christine;
MacKay, Andrew J;
Ip, Michael;
Kannan, Ram

Publication type:

Article

Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.

Published in:

2017

By:

Scott, Ingrid U.;
VanVeldhuisen, Paul C.;
Ip, Michael S.;
Blodi, Barbara A.;
Oden, Neal L.;
Awh, Carl C.;
Kunimoto, Derek Y.;
Marcus, Dennis M.;
Wroblewski, John J.;
King, Jacqueline;
SCORE2 Investigator Group

Publication type:

journal article

Optimizing the Use of Intravitreal Anti-VEGF Agents in the Treatment of Diabetic Macular Edema.

Published in:

Ocular Surgery News, 2012, p. 3

By:

Ip, Michael S.

Publication type:

Article

Time is now for retina exams to move from slit lamp to OCT biomicroscopy.

Published in:

Ocular Surgery News, 2012, v. 30, n. 4, p. 11

By:

Correa, Mark;
Hasson, Matt;
Mullin, David W.;
Pagnani, Michelle;
Ip, Michael S.

Publication type:

Article

FDA issues alert after repackaged bevacizumab causes endophthalmitis infections in Florida.

Published in:

Ocular Surgery News, 2011, v. 29, n. 18, p. 1

By:

Ip, Michael S.;
Williams, George A.

Publication type:

Article

What recommendations do you make to your AMD patients regarding antioxidant vitamins and supplements specifically formulated to help prevent disease progression?

Published in:

Ocular Surgery News, 2010, v. 28, n. 22, p. 11

By:

Ip, Michael S.;
Bernstein, Paul S.

Publication type:

Article

Outcomes of Rhegmatogenous Retinal Detachment Repair When Comparing Surgeon Continuity in a Team-Based Practice.

Published in:

2021

By:

Raevis, Joseph J.;
Oakey, Zackery;
Altaweel, Michael;
Nork, T. Michael;
Gottlieb, Justin;
Ip, Michael;
Downie, Elaine;
Lasarev, Michael;
Chang, Jonathan S.

Publication type:

journal article

Propranolol for Proliferative Diabetic Retinopathy.

Published in:

2018

By:

Hendrick, Andrew M.;
Lavine, Jeremy;
Domalpally, Amitha;
Kulkarni, Amol D.;
Ip, Michael S.;
Lavine, Jeremy A

Publication type:

journal article

Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study.

Published in:

2003

By:

Ip M;
Kahana A;
Altaweel M;
Ip, Michael;
Kahana, Alon;
Altaweel, Michael

Publication type:

journal article

Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study.

Published in:

Seminars in Ophthalmology, 2003, v. 18, n. 2, p. 67, doi. 10.1076/soph.18.2.67.15860

By:

Michael Ip;
Alon Kahana;
Michael Altaweel

Publication type:

Article

Macular hole: improved understanding of pathogenesis, staging, and management based on optical coherence tomography.

Published in:

Seminars in Ophthalmology, 2003, v. 18, n. 2, p. 58, doi. 10.1076/soph.18.2.58.15858

By:

Michael Altaweel;
Michael Ip

Publication type:

Article

Transpupillary Thermotherapy.

Published in:

Seminars in Ophthalmology, 1999, v. 14, n. 1, p. 11, doi. 10.3109/08820539909056058

By:

Ip, Michael;
Kroll, Arnold;
Reichel, Elias

Publication type:

Article

SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 5, p. 1491, doi. 10.1007/s00417-021-05494-5

By:

Scott, Ingrid U.;
Oden, Neal L.;
VanVeldhuisen, Paul C.;
Ip, Michael S.;
Blodi, Barbara A.

Publication type:

Article

Disease-modifying effects of ranibizumab for central retinal vein occlusion.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 3, p. 799, doi. 10.1007/s00417-021-05224-x

By:

Huang, Jason M.;
Khurana, Rahul N.;
Ghanekar, Avanti;
Wang, Pin-wen;
Day, Bann-Mo;
Blodi, Barbara A.;
Domalpally, Amitha;
Quezada-Ruiz, Carlos;
Ip, Michael S.

Publication type:

Article

Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents: SCORE2 report 12: secondary analysis of the SCORE2 clinical trial.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 7, p. 1839, doi. 10.1007/s00417-020-05018-7

By:

Khurana, Rahul N.;
Oden, Neal L.;
VanVeldhuisen, Paul C.;
Scott, Ingrid U.;
Blodi, Barbara A.;
Ip, Michael S.

Publication type:

Article